After Serum Institute, Bharat Biotech has announced that it will sell its Covid-19 vaccine, Covaxin at Rs. 600 to state hospitals and at Rs. 1,200 to private hospitals. The company said that it will export the vaccine at $15-20 per dose.
“Bharat Biotech is honoured to develop, manufacture and supply Covaxin for India’s vaccine rollout at Rs 150 per dose, which is distributed for free by the Government of India. We would like to state that more than 50% of our capacities have been reserved for central government supplies,” it added.
Managing Director and Chairman of Bharat Biotech, Krishna Ella said, “Recovering costs is essential in the journey of innovation towards other vaccines such as intranasal COVID-19, chikungunya, zika, cholera and others. Our core mission for the last 25 years has been to provide affordable yet world class healthcare solutions for the globe.”
